GGrantIndex
← Leaderboards

Jing Zhou

Isoplexis, Inc.

$8,086,644
Attributed
$16,013,002
Total exposure
9
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.6M · FY201621
$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$16,013,002 · 9

By mechanism

R44$15,465,236 · 6
R43$547,766 · 3

Top collaborators

Most similar at Isoplexis, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Proteins

Research focus

ProteinsSamplingCellsTechnologyDevicesMonitorResponseAntibodiesCytokineBaseSuccessT-LymphocyteFlow CytometryProteomicsImmunotherapySmall Business Innovation Research GrantAutomationImmuneClinical TrialsBiological MarkersFailureDetectionGoldInstrument

Grant awards (20)

A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies$1,150,207
R44 · FY2021 · CA · contact PI
A Single-cell Platform for Analyzing the Peripheral Immune Response in Alzheimer’s and Alzheimer’s Related Diseases$994,372
R44 · FY2021 · AG
A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies$1,150,207
R44 · FY2020 · CA · contact PI
A Single-cell Platform for Analyzing the Peripheral Immune Response in Alzheimer’s and Alzheimer’s Related Diseases$999,615
R44 · FY2020 · AG
Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance$961,259
R44 · FY2020 · CA · contact PI
A Single-Cell Proteomic instrument for Predictive Product Quality Check in Autologous CAR-T Immunotherapies$1,699,322
R44 · FY2019 · CA · contact PI
Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance$999,016
R44 · FY2019 · CA · contact PI
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics$599,799
R44 · FY2019 · OD
Age-dependent Single-cell Metabolomic and Proteomic Profiling of Human Immune System$224,947
R43 · FY2019 · AG
A single-cell device to capture and analyze rare T-cells from solid tumors.$920,072
R44 · FY2018 · CA
Precision quality check of immunotherapeutics via single-cell cytokine mapping$910,459
R44 · FY2018 · CA · contact PI
A Single-Cell Device to Detect Pathogenic Cell Populations in Bone Marrow Disease$845,621
R44 · FY2018 · EB
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics$599,799
R44 · FY2018 · OD
Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance$224,633
R44 · FY2018 · CA · contact PI
A single-cell device to capture and analyze rare T-cells from solid tumors.$991,227
R44 · FY2017 · CA
Precision quality check of immunotherapeutics via single-cell cytokine mapping$974,208
R44 · FY2017 · CA · contact PI
A Single-Cell Device to Detect Pathogenic Cell Populations in Bone Marrow Disease$845,621
R44 · FY2017 · EB
A single-cell mouse proteomic system to accelerate pre-clinical immune therapeutics$599,799
R44 · FY2017 · OD
Developing an integrated sorting and single cell analysis tool for the analysis of rare T Cells subsets in Autoimmunity$162,533
R43 · FY2017 · AI · contact PI
Precision Quality Check of Immunotherapeutics via Single Cell Cytokine Mapping$160,286
R43 · FY2016 · CA · contact PI